Could a pill replace CPAP for sleep apnea heart risks?
NCT ID NCT00777985
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 19 people with sleep apnea and mild high blood pressure. It compared a drug called bosentan to the standard CPAP machine to see if the drug could lower blood pressure just as well. The goal was to find a simpler way to manage heart risks in sleep apnea patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTENSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU de Grenoble
Grenoble, 38043, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Squeeze away hypertension? handgrip device put to the test
- Blood pressure cuffs and health classes: a new approach to close a heart health gap
- AI tailors lifestyle tips to tackle high blood pressure
- Could a simple clinic Check-In change catch hidden high blood pressure and diabetes?
- Home visits may boost heart health for pregnant women in nigeria
- Could removing tonsils supercharge a sleep apnea implant?